The details of the Kronox Lab Sciences IPO are as follows: The IPO is scheduled to take place on June 3 and will conclude on June 5. Kronox Lab Sciences plans to generate about ₹130.15 crores through an initial public offering (IPO). The IPO will involve selling up to 9,570,000 equity shares with a face value of ₹10 apiece. The allocation for ordinary investors is 35%, qualified institutional buyers (QIB) receive 50%, and high net worth individuals (HNI) are allotted 15%.
Kronox Lab Sciences produces very pure specialty fine chemicals for a wide range of industries. Their Purity Speciality Fine Chemicals are primarily utilized as
- (i) reactants and raw materials in the production of Active Pharmaceutical Ingredients (APIs);
- (ii) additives in pharmaceutical formulations;
- (iii) reagents for scientific research and laboratory testing;
- (iv) components in nutraceutical formulations;
- (v) intermediate products and agents for fermentation in biotech applications;
- (vi) constituents in agrochemical formulations;
- (vii) constituents in personal care products;
- (viii) agents for refining in metal refineries; and
- (ix) constituents in animal health products, among other applications. Their goods are created according to industry standards such as IP, BP, EP, JP, USP, FCC, LR, AR, GR, and ACS, as well as unique manufacturing specifications that vary from the industry standards as per the specific requirements of their clients in certain situations.
The company produces specialized fine chemicals with high purity in several grades, available in particle sizes ranging from 10 mesh to 100 mesh. Their emphasis on product creation, diverse product options, adherence to quality standards and customer specifications, and ongoing process improvement are believed to be the reasons for their customers’ repeated orders throughout the years.
Table of Contents
They offer a diverse selection of over 185 items, including phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, and gluconate, which are distributed to consumers in India and over 20 countries worldwide.
The company operates three (3) Manufacturing Facilities located in Vadodara, Gujarat, which are strategically positioned near the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. Their Manufacturing Facilities include a total area of 17,454 square meters and, as of December 31, 2023, have a combined installed capacity of 7,242 tons per annum. Their Unit I/II possess certifications like FSSC 22000 (Version 5), ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018.
In addition, they have acquired certifications such as Kosher, Halal, GMP, and GLP for some products produced at Unit I. To obtain more information, refer to the section under “Manufacturing Facilities Certifications” on page 190. In addition, they have obtained a plot of land spanning 20,471 square meters at the GIDC – Dahej II Industrial Estate.
Objects of the Issue
- Execute the Offer for Sale of a maximum of 95,70,000 Equity Shares by the Promoter Selling Shareholders;
- Attain the advantages of having the Equity Shares listed on the Stock Exchanges. Additionally, the Company anticipates that the planned listing of the Equity Shares will improve the company’s visibility and brand reputation, offer liquidity to its current Shareholders, and establish a public market for Equity Shares in India.
Kronox Lab Sciences IPO Review (Apply or Not)
- May Apply (Recommended for Application)
Kronox Lab Sciences IPO Date & Price Band Details
| IPO Open: | June 3, 2024 |
| IPO Close: | June 5, 2024 |
| IPO Size: | Approx ₹130.15 Crores |
| Offer for Sale: | Approx ₹9,570,000 Equity Shares |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹129 to ₹136 Per Share |
| IPO Listing on: | BSE & NSE |
| Retail Quota: | 35% |
| QIB Quota: | 50% |
| NII Quota: | 15% |
| Discount: | N/A |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
The market lot for the Kronox Lab Sciences IPO is currently undisclosed.
The minimum market lot for the Kronox Lab Sciences IPO is 110 shares, with an application amount of ₹14,960. Retail investors have the option to apply for a maximum of 13 lots, which is equivalent to 1430 shares or a sum of ₹194,480.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 110 | ₹14,960 |
| Retail Maximum | 13 | 1430 | ₹194,480 |
| S-HNI Minimum | 14 | 1540 | ₹209,440 |
| B-HNI Minimum | 67 | 7370 | ₹1,002,320 |
Kronox Lab Sciences IPO Allotment and Listing Dates
The initial public offering (IPO) of Kronox Lab Sciences is scheduled for June 3, with the closing date set for June 5. The allocation of shares for the Kronox Lab Sciences initial public offering (IPO) will be determined on June 6, and the IPO will be officially listed on June 10.
| IPO Open Date: | June 3, 2024 |
| IPO Close Date: | June 5, 2024 |
| Basis of Allotment: | June 6, 2024 |
| Refunds: | June 7, 2024 |
| Credit to Demat Account: | June 7, 2024 |
| IPO Listing Date: | June 10, 2024 |
Initial Public Offering (IPO) Form for Kronox Lab Sciences
What is the process for submitting an application for the Kronox Lab Sciences IPO? To participate in the Kronox Lab Sciences IPO, you can submit your application through the ASBA facility provided in your bank account. To apply for the Kronox Lab Sciences IPO, simply access the online bank login and pick the Invest area. From there, apply using your bank account. Alternatively, you have the option to apply for the Kronox Lab Sciences IPO by downloading IPO forms from NSE and BSE. Explore the Kronox Lab Sciences forms by clicking on the BSE Forms & NSE Forms. Download the blank IPO forms, complete them, and then submit them either at your bank or with your broker.
Kronox Lab Sciences Company Financial Report
| ₹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2021 | ₹63.24 | ₹50.02 | ₹9.73 |
| 2022 | ₹83.34 | ₹64.99 | ₹13.63 |
| 2023 | ₹97.50 | ₹75.17 | ₹16.62 |
| Dec 2023 | ₹68.44 | ₹48.22 | ₹15.47 |
Kronox Lab Sciences IPO Valuation – FY2023
Please provide the valuations details of Kronox Lab Sciences IPO, including Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV).
| Earning Per Share (EPS): | ₹4.30 per Equity Share |
| Price/Earning P/E Ratio: | 30.00 |
| Return on Net Worth (RoNW): | 37.19% |
| Net Asset Value (NAV): | ₹12.04 per Equity Share |
Peer Group
- Tatva Chintan Pharma Chem Limited
- Tanfac Industries Limited
- Neogen Chemicals Limited
- Sigachi Industries Limited
- DMCC Speciality Chemical Limited
Company Promoters
- Jogindersingh Jaswal
- Ketan Ramani
- Pritesh Ramani
Kronox Lab Sciences IPO Registrar
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: klsl.ipo@kfintech.com
Website: https://kosmic.kfintech.com/
Kronox Lab Sciences IPO Allotment Status Check
Check Kronox Lab Sciences IPO allotment status on Kfin Technologies website allotment URL. Click Here
Kronox Lab Sciences IPO Lead Managers aka Merchant Bankers
- Pantomath Capital Advisors Pvt Ltd
Company Address
Kronox Lab Sciences Limited
Block No. 353,
Village Ekalbara, Padra,
Vadodara-391440
Phone: +91 26 6224 4077/88
Email: cs@kronoxlabsciences.com
Website: https://www.kronoxlabsciences.com/
Frequently Asked Questions about the Kronox Lab Sciences Initial Public Offering (IPO)
The Initial Public Offering (IPO) is scheduled to commence on June 3, 2024, and will be open to Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII), and Retail Investors.
The allocation for Qualified Institutional Buyers (QIB) is 50%, Non-Institutional Investors (NII) is 15%, and Retail investors is 35%.
To participate in the Kronox Lab Sciences IPO, you can conveniently apply online through your bank account using the ASBA facility. Additionally, you have the option to submit your ASBA application online using UPI through your stock brokers. An alternative method of application is to submit the offline form through your stock brokers.
Access the Zerodha website or application and proceed to log in to the console. Navigate to the Portfolio section and select the IPO option. The IPO Name “Kronox Lab Sciences” will be visible to you. Please select the “Bid” button. Please include your UPI ID, Quantity, and Price. Complete and submit the Initial Public Offering (IPO) application form. Proceed to your UPI App on Net Banking or BHIM App in order to authorize the mandate. Start a Demat Account with Zerodha.
Access the Upstox Application by logging in with your credentials. Choose the Initial Public Offering (IPO). The IPO Name “Kronox Lab Sciences” will be visible to you. Please select the “Bid” button. Please verify your application. Proceed to your UPI App on Net Banking or BHIM App in order to authorize the mandate. Start a Demat Account with Upstox.
Access the Paytm Money Application by entering your login details. Choose the Initial Public Offering (IPO). The IPO Name “Kronox Lab Sciences” will be visible to you. Please select the “Bid” button. Please verify your application. Proceed to your UPI App on Net Banking or BHIM App in order to authorize the mandate. Start a Demat Account with Paytm Money.
The first public offering (IPO) size of Kronox Lab Sciences is ₹130.15 crores.
The price range for the Kronox Lab Sciences IPO is set at ₹129 to ₹136.
The lowest bid amount is ₹14,960 for 110 shares, while the maximum bid amount is ₹194,480 for 13 shares.
The allotted date for the Kronox Lab Sciences IPO is scheduled for June 6, 2024.
The initial public offering (IPO) of Kronox Lab Sciences is scheduled to be listed on June 10, 2024. The Initial Public Offering (IPO) will be listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
The formal announcement has been made about the price band and date of the Kronox Lab Sciences IPO. The IPO grey market premium for Kronox Lab Sciences IPO will be included on the IPO grey market page as it becomes available.